R1 RCM (RCM) Inflated Revenue and Departures of Key Officers Case
重点：
- In October 2023 RCM’s (RCM) revenues were chronically inflated, and that the Company has recently seen the departures of the CEO, CFO, CCO and CSO.
- On it, fell 8.3%, losing $456M+ of shareholder value.
- Investors may have grounds to suspect that RCM was systematically engaged in inaccurate reporting, which led to their losses.
On October 16, 2023, Jehoshaphat Research published a report alleging that RCM’s revenues and profits are grossly overstated, which will eventually “collapse,” and that the Company’s revenue is “chronically inflated.” The report also points out that RCM has recently seen the departures of the CEO, CFO, CCO and CSO, which speak to the risks that have surfaced.
On this news, RRCM fell 8.3% and lost over $456 million of its market capitalization, seriously damaging shareholders.
Considering all the information, investors might have grounds to suspect that RCM failed to timely disclose its inaccurate reporting practices, which led to their losses.
The case is already under investigation by at least one of the reputable law firms.